Vascular Boot Warming Program After Acute Deep Vein Thrombosis (DVT) ± Pulmonary Embolism (PE)

• Status: Terminated
• Trial end date: 2020-01-03
• Target enrollment: 0
• Participant gender: All

Summary

The Researchers are studying whether a vascular boot warming program plus standard of care anticoagulation can be a safe and effective method to resolve Deep Vein Thrombosis (DVT) ±Pulmonary Embolism (PE) earlier and prevent development of post-thrombotic syndrome (PTS). Additionally, to learn whether a more detailed imaging of the affected lower extremities will provide a more accurate and reliable method to guide treatment for this condition.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Mayo Clinic
• Treatments: Apixaban; Dabigatran; Dalteparin; Edoxaban; Enoxaparin; Heparin; Rivaroxaban; Warfarin

Criteria

Inclusion Criteria:

• Able to tolerate wearing a vascular boot, if randomized to this group.

• Diagnosis of acute DVT±PE (within 24 - 48 hours) and received approximately 24 hours of anticoagulation prior to starting the study.

Exclusion Criteria:

• Unable to tolerate wearing a vascular boot

• Unable to comply with keeping log of activity/ of wearing a vascular boot.

• Weight > 300 pounds. (weight limit for the venous plethysmography chair)

• Previous history of DVT or PE.

• On anticoagulation for another purpose (example stroke prevention with atrial fibrillation).

• Patients who do not accept to participate in research studies.

• Pregnant women will not be allowed to participate

• Patients less than 18 yrs